Studies of Inherited Diseases of Metabolism

Plain-language summary

This study investigates familial hyperparathyroidism and related inherited metabolic diseases. It includes affected individuals and their first-degree relatives across kindreds such as MEN1, HPT-JT, FIHP, and FHH. No phase is specified; the study is completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Start date

8/19/1993

Estimated completion

1/13/2023

Countries

United States

Related genes

Locations

• Bethesda, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

* ELIGIBILITY CRITERIA:

  1. Patient has possible form of familial hyperparathyroidism. Or case is a clinically unaffected first degree relative of such a patient.
  2. The lower age limit to enter a clinically affected minor into the study is \>= 4 years old. However, asymptomatic and possibly unaffected cases will not be enrolled, and blood will not be drawn, before age 5 years in MEN1, MEN1-like, HPT-JT, or FIHP kindreds or before age 10 in FHH kindreds.